DA-9701 is named as an intervention in 2 current clinical trials in our South Korea register. 1 is recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Eunpyeong St. Mary's Hospital (1). The most-studied condition is Functional Dyspepsia.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia
NCT07686679 · ClinicalTrials.gov ↗ · Functional Dyspepsia
|
Phase 4 | Recruiting | Dong-A ST Co., Ltd | South Korea |
|
The Effect of Two Prokinetics in Patients With Functional Dyspepsia
NCT07096921 · ClinicalTrials.gov ↗ · Functional Dyspepsia
|
Not applicable | Active, closed | Eunpyeong St. Mary's Hospital | South Korea |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Eunpyeong St. Mary's Hospital | 1 |
| Dong-A ST Co., Ltd | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in South Korea | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our South Korea register name DA-9701 as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in South Korea. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Eunpyeong St. Mary's Hospital (1) and Dong-A ST Co., Ltd (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how DA-9701 works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how DA-9701 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists DA-9701 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.